PolyNovo Past Earnings Performance

Past criteria checks 3/6

PolyNovo has been growing earnings at an average annual rate of 29.2%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 37.1% per year. PolyNovo's return on equity is 7.3%, and it has net margins of 5.1%.

Key information

29.2%

Earnings growth rate

29.2%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate37.1%
Return on equity7.3%
Net Margin5.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?

Oct 10
Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?

PolyNovo (ASX:PNV) Is Experiencing Growth In Returns On Capital

Aug 28
PolyNovo (ASX:PNV) Is Experiencing Growth In Returns On Capital

PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

Aug 06
PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

May 08
PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

When Should You Buy PolyNovo Limited (ASX:PNV)?

Feb 28
When Should You Buy PolyNovo Limited (ASX:PNV)?

Why Investors Shouldn't Be Surprised By PolyNovo Limited's (ASX:PNV) P/S

Feb 02
Why Investors Shouldn't Be Surprised By PolyNovo Limited's (ASX:PNV) P/S

PolyNovo Limited (ASX:PNV) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 08
PolyNovo Limited (ASX:PNV) Shares Could Be 47% Below Their Intrinsic Value Estimate

Health Check: How Prudently Does PolyNovo (ASX:PNV) Use Debt?

Sep 22
Health Check: How Prudently Does PolyNovo (ASX:PNV) Use Debt?

When Should You Buy PolyNovo Limited (ASX:PNV)?

Jun 26
When Should You Buy PolyNovo Limited (ASX:PNV)?

Are Investors Undervaluing PolyNovo Limited (ASX:PNV) By 29%?

May 30
Are Investors Undervaluing PolyNovo Limited (ASX:PNV) By 29%?

Shareholders Should Be Pleased With PolyNovo Limited's (ASX:PNV) Price

Apr 18
Shareholders Should Be Pleased With PolyNovo Limited's (ASX:PNV) Price

Is It Too Late To Consider Buying PolyNovo Limited (ASX:PNV)?

Mar 23
Is It Too Late To Consider Buying PolyNovo Limited (ASX:PNV)?

Is PolyNovo Limited (ASX:PNV) Worth AU$2.6 Based On Its Intrinsic Value?

Feb 05
Is PolyNovo Limited (ASX:PNV) Worth AU$2.6 Based On Its Intrinsic Value?

Returns At PolyNovo (ASX:PNV) Are On The Way Up

Nov 16
Returns At PolyNovo (ASX:PNV) Are On The Way Up

PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

Nov 01
PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?

Jul 29
What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?

PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital

Jun 15
PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital

Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)

May 16
Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)

We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt

Apr 28
We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt

There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital

Mar 07
There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital

Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?

Dec 13
Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?

PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 19
PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why

Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?

May 08
Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?

News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat

Feb 27
News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat

Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts

Feb 25
Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts

Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?

Feb 17
Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?

Revenue & Expenses Breakdown

How PolyNovo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:PNV Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241035810
31 Mar 24933740
31 Dec 23832690
30 Sep 2375-2630
30 Jun 2366-5550
31 Mar 2359-6510
31 Dec 2253-7470
30 Sep 2248-4390
30 Jun 2242-1320
31 Mar 22380290
31 Dec 21351260
30 Sep 2132-2270
30 Jun 2129-5270
31 Mar 2127-5260
31 Dec 2025-5250
30 Sep 2024-5230
30 Jun 2022-4210
31 Mar 2020-4190
31 Dec 1918-4170
30 Sep 1916-3150
30 Jun 1914-3120
31 Mar 1912-4110
31 Dec 189-590
30 Sep 188-590
30 Jun 187-680
31 Mar 186-680
31 Dec 175-680
30 Sep 174-680
30 Jun 174-570
31 Mar 174-460
31 Dec 165-350
30 Sep 164-350
30 Jun 163-350
31 Mar 162-340
31 Dec 150-240
30 Sep 150-230
30 Jun 150-130
31 Mar 150-230
31 Dec 140-330
30 Sep 140-330
30 Jun 140-330
31 Mar 140-230
31 Dec 130-220

Quality Earnings: PNV has high quality earnings.

Growing Profit Margin: PNV became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PNV has become profitable over the past 5 years, growing earnings by 29.2% per year.

Accelerating Growth: PNV has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: PNV has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).


Return on Equity

High ROE: PNV's Return on Equity (7.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies